BrainsWay (BWAY) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

BWAY Stock Forecast


BrainsWay stock forecast is as follows: an average price target of $10.00 (represents a 10.62% upside from BWAY’s last price of $9.04) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

BWAY Price Target


The average price target for BrainsWay (BWAY) is $10.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $16.00 to $5.00. This represents a potential 10.62% upside from BWAY's last price of $9.04.

BWAY Analyst Ratings


Buy

According to 3 Wall Street analysts, BrainsWay's rating consensus is 'Buy'. The analyst rating breakdown for BWAY stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

BrainsWay Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2024Raghuram SelvarajuH.C. Wainwright$16.00$6.89132.22%76.99%
May 09, 2024Steven LichtmanOppenheimer$11.00$5.7092.98%21.68%
May 09, 2024Raghuram SelvarajuH.C. Wainwright$15.00$5.70163.16%65.93%
Nov 17, 2022-Northland Securities$5.00$1.98152.53%-44.69%
Aug 22, 2022-H.C. Wainwright$16.00$4.92225.20%76.99%
Aug 11, 2022-Raymond James$8.00$5.6741.09%-11.50%
Row per page
Go to

The latest BrainsWay stock forecast, released on Aug 07, 2024 by Raghuram Selvaraju from H.C. Wainwright, set a price target of $16.00, which represents a 132.22% increase from the stock price at the time of the forecast ($6.89), and a 76.99% increase from BWAY last price ($9.04).

BrainsWay Price Target by Period


1M3M12M
# Anlaysts--3
Avg Price Target--$14.00
Last Closing Price$9.04$9.04$9.04
Upside/Downside-100.00%-100.00%54.87%

In the current month, the average price target of BrainsWay stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to BrainsWay's last price of $9.04. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 21, 2024H.C. WainwrightBuyBuyHold
Sep 17, 2024H.C. WainwrightBuyBuyHold
Aug 07, 2024H.C. WainwrightBuyBuyHold
May 09, 2024OppenheimerOutperformOutperformHold
May 09, 2024H.C. WainwrightBuyBuyHold
Aug 11, 2022Raymond JamesOutperformOutperformHold
Row per page
Go to

BrainsWay's last stock rating was published by H.C. Wainwright on Oct 21, 2024. The company gave BWAY a "Buy" rating, the same as its previous rate.

BrainsWay Financial Forecast


BrainsWay Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue---------------$6.63M$6.03M$5.17M$8.01M$7.97M-$8.06M$7.00M--$6.01M$4.82M--$5.93M
Avg Forecast$16.20M$14.90M$14.30M$13.80M$12.37M$11.70M$11.33M$10.80M$10.67M$10.08M$9.53M$8.72M$8.65M$7.74M$7.08M$6.40M$6.30M$8.45M$8.42M$7.45M$8.24M$6.83M$6.25M$5.81M$6.94M$5.45M$4.78M$4.55M$6.20M$5.75M
High Forecast$16.20M$14.90M$14.30M$13.80M$12.37M$11.70M$11.33M$10.80M$10.67M$10.31M$9.53M$8.72M$8.75M$7.74M$7.08M$6.40M$6.30M$8.45M$8.42M$7.45M$8.24M$6.83M$6.25M$5.81M$6.94M$5.45M$4.78M$4.55M$6.20M$5.75M
Low Forecast$16.20M$14.90M$14.30M$13.80M$12.37M$11.70M$11.33M$10.80M$10.67M$9.81M$9.53M$8.72M$8.55M$7.74M$7.08M$6.40M$6.30M$8.45M$8.42M$7.45M$8.24M$6.83M$6.25M$5.81M$6.94M$5.45M$4.78M$4.55M$6.20M$5.75M
# Analysts111111111311211111111111111111
Surprise %---------------1.04%0.96%0.61%0.95%1.07%-1.18%1.12%--1.10%1.01%--1.03%

BrainsWay's average Quarter revenue forecast for Jun 23 based on 1 analysts is $7.08M, with a low forecast of $7.08M, and a high forecast of $7.08M. BWAY's average Quarter revenue forecast represents a 6.90% increase compared to the company's last Quarter revenue of $6.63M (Mar 23).

BrainsWay EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311211111111111111111
EBITDA---------------$-3.34M$-3.98M$-4.47M$-1.61M$-1.09M-$-440.00K$-867.00K--$248.00K$360.00K--$-1.46M
Avg Forecast$-3.69M$-3.39M$-3.26M$-3.14M$-2.82M$-2.66M$-2.58M$-2.46M$-2.43M$-2.29M$-2.17M$-1.99M$-1.97M$-1.76M$-1.61M$-1.46M$-1.43M$-1.92M$-1.92M$-1.70M$-1.88M$-1.55M$-1.30M$-1.32M$-1.58M$-1.24M$250.62K$-1.04M$-1.41M$-1.31M
High Forecast$-3.69M$-3.39M$-3.26M$-3.14M$-2.82M$-2.66M$-2.58M$-2.46M$-2.43M$-2.23M$-2.17M$-1.99M$-1.95M$-1.76M$-1.61M$-1.46M$-1.43M$-1.92M$-1.92M$-1.70M$-1.88M$-1.55M$-1.04M$-1.32M$-1.58M$-1.24M$300.74K$-1.04M$-1.41M$-1.31M
Low Forecast$-3.69M$-3.39M$-3.26M$-3.14M$-2.82M$-2.66M$-2.58M$-2.46M$-2.43M$-2.35M$-2.17M$-1.99M$-1.99M$-1.76M$-1.61M$-1.46M$-1.43M$-1.92M$-1.92M$-1.70M$-1.88M$-1.55M$-1.56M$-1.32M$-1.58M$-1.24M$200.49K$-1.04M$-1.41M$-1.31M
Surprise %---------------2.29%2.77%2.32%0.84%0.65%-0.28%0.67%---0.20%1.44%--1.12%

1 analysts predict BWAY's average Quarter EBITDA for Dec 20 to be $-1.58M, with a high of $-1.58M and a low of $-1.58M. This is -737.11% lower than BrainsWay's previous annual EBITDA (Sep 20) of $248.00K.

BrainsWay Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311211111111111111111
Net Income---------------$-2.43M$-3.87M$-5.04M$-2.45M$-1.99M-$-1.80M$-1.94M--$-966.00K$-571.00K--$-2.63M
Avg Forecast$1.35M$1.05M$1.05M$900.00K$450.00K$400.00K$350.00K$250.00K$262.50K$150.00K$-37.50K$-247.50K$-195.06K$-671.10K$-1.25M$-1.62M$-1.88M$-1.06M$-1.17M$-1.22M$-972.10K$-1.03M$-2.21M$-1.27M$-833.23K$-958.22K$-790.62K$-2.54M$-1.96M$-2.08M
High Forecast$1.35M$1.05M$1.05M$900.00K$450.00K$400.00K$350.00K$250.00K$262.50K$300.00K$-37.50K$-247.50K$-130.04K$-671.10K$-1.25M$-1.62M$-1.88M$-1.06M$-1.17M$-1.22M$-972.10K$-1.03M$-1.77M$-1.27M$-833.23K$-958.22K$-632.49K$-2.54M$-1.96M$-2.08M
Low Forecast$1.35M$1.05M$1.05M$900.00K$450.00K$400.00K$350.00K$250.00K$262.50K$150.00K$-37.50K$-247.50K$-260.08K$-671.10K$-1.25M$-1.62M$-1.88M$-1.06M$-1.17M$-1.22M$-972.10K$-1.03M$-2.66M$-1.27M$-833.23K$-958.22K$-948.74K$-2.54M$-1.96M$-2.08M
Surprise %---------------1.50%2.06%4.77%2.10%1.63%-1.75%0.88%--1.01%0.72%--1.26%

BrainsWay's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. BWAY's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

BrainsWay SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311211111111111111111
SG&A---------------$6.71M$6.48M$6.48M$6.09M$6.01M-$5.58M$5.57M--$3.70M$3.00M--$5.04M
Avg Forecast$12.37M$11.38M$10.92M$10.54M$9.44M$8.94M$8.66M$8.25M$8.15M$7.69M$7.27M$6.66M$6.60M$5.91M$5.41M$4.89M$4.81M$6.45M$6.43M$5.69M$6.29M$5.21M$4.77M$4.44M$5.30M$4.16M$4.16M$3.47M$4.73M$4.39M
High Forecast$12.37M$11.38M$10.92M$10.54M$9.44M$8.94M$8.66M$8.25M$8.15M$7.87M$7.27M$6.66M$6.68M$5.91M$5.41M$4.89M$4.81M$6.45M$6.43M$5.69M$6.29M$5.21M$4.77M$4.44M$5.30M$4.16M$4.99M$3.47M$4.73M$4.39M
Low Forecast$12.37M$11.38M$10.92M$10.54M$9.44M$8.94M$8.66M$8.25M$8.15M$7.49M$7.27M$6.66M$6.53M$5.91M$5.41M$4.89M$4.81M$6.45M$6.43M$5.69M$6.29M$5.21M$4.77M$4.44M$5.30M$4.16M$3.33M$3.47M$4.73M$4.39M
Surprise %---------------1.37%1.35%1.00%0.95%1.06%-1.07%1.17%--0.89%0.72%--1.15%

BrainsWay's average Quarter SG&A projection for Jun 23 is $5.41M, based on 1 Wall Street analysts, with a range of $5.41M to $5.41M. The forecast indicates a -19.46% fall compared to BWAY last annual SG&A of $6.71M (Mar 23).

BrainsWay EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts111111111311211111111111111111
EPS---------------$-0.14$-0.24$-0.30$-0.14$-0.12-$-0.10$-0.12--$-0.08$-0.06--$-0.24
Avg Forecast$0.09$0.07$0.07$0.06$0.03$0.03$0.02$0.02$0.02$0.01$-0.00$-0.02$-0.01$-0.04$-0.08$-0.11$-0.13$-0.06$-0.07$-0.07$-0.06$-0.06$-0.07$-0.08$-0.05$-0.06$-0.12$-0.15$-0.12$-0.13
High Forecast$0.09$0.07$0.07$0.06$0.03$0.03$0.02$0.02$0.02$0.02$-0.00$-0.02$-0.01$-0.04$-0.08$-0.11$-0.13$-0.06$-0.07$-0.07$-0.06$-0.06$-0.07$-0.08$-0.05$-0.06$-0.12$-0.15$-0.12$-0.13
Low Forecast$0.09$0.07$0.07$0.06$0.03$0.03$0.02$0.02$0.02$0.01$-0.00$-0.02$-0.02$-0.04$-0.08$-0.11$-0.13$-0.06$-0.07$-0.07$-0.06$-0.06$-0.07$-0.08$-0.05$-0.06$-0.12$-0.15$-0.12$-0.13
Surprise %---------------1.30%1.92%4.74%2.00%1.64%-1.61%1.82%--1.39%0.49%--1.92%

According to undefined Wall Street analysts, BrainsWay's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to BWAY previous annual EPS of $NaN (undefined).

BrainsWay Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
VAPOVapotherm$2.17$128.005798.62%Hold
VEROVenus Concept$0.34$5.501517.65%Buy
AZYOElutia$1.49$10.25587.92%Buy
DCTHDelcath Systems$9.41$22.00133.79%Buy
KIDSOrthoPediatrics$24.26$39.6063.23%Buy
NPCENeuroPace$9.15$12.8840.77%Buy
OFIXOrthofix Medical$18.64$24.0028.76%-
CVRXCVRx$14.20$16.3315.00%Buy
AORTArtivion$27.21$30.6012.46%Buy
FNAParagon 28$10.30$11.5011.65%Buy
BWAYBrainsWay$9.04$10.0010.62%Buy
SRDXSurmodics$38.17$39.503.48%Buy
TCMDTactile Systems$16.22$16.00-1.36%Buy

BWAY Forecast FAQ


Is BrainsWay a good buy?

Yes, according to 3 Wall Street analysts, BrainsWay (BWAY) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of BWAY's total ratings.

What is BWAY's price target?

BrainsWay (BWAY) average price target is $10 with a range of $5 to $16, implying a 10.62% from its last price of $9.04. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will BrainsWay stock go up soon?

According to Wall Street analysts' prediction for BWAY stock, the company can go up by 10.62% (from the last price of $9.04 to the average price target of $10), up by 76.99% based on the highest stock price target, and down by -44.69% based on the lowest stock price target.

Can BrainsWay stock reach $14?

BWAY's highest twelve months analyst stock price target of $16 supports the claim that BrainsWay can reach $14 in the near future.

What are BrainsWay's analysts' financial forecasts?

BrainsWay's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $46.2M (high $46.2M, low $46.2M), average EBITDA is $-10.522M (high $-10.522M, low $-10.522M), average net income is $1.45M (high $1.45M, low $1.45M), average SG&A $35.28M (high $35.28M, low $35.28M), and average EPS is $0.0967 (high $0.0967, low $0.0967). BWAY's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $59.2M (high $59.2M, low $59.2M), average EBITDA is $-13.483M (high $-13.483M, low $-13.483M), average net income is $4.35M (high $4.35M, low $4.35M), average SG&A $45.21M (high $45.21M, low $45.21M), and average EPS is $0.29 (high $0.29, low $0.29).

Did the BWAY's actual financial results beat the analysts' financial forecasts?

Based on BrainsWay's last annual report (Dec 2022), the company's revenue was $27.18M, which missed the average analysts forecast of $30.62M by -11.23%. Apple's EBITDA was $-11.148M, beating the average prediction of $-6.973M by 59.88%. The company's net income was $-13.349M, beating the average estimation of $-5.319M by 150.97%. Apple's SG&A was $25.05M, beating the average forecast of $23.38M by 7.15%. Lastly, the company's EPS was $-0.87, beating the average prediction of $-0.332 by 162.31%. In terms of the last quarterly report (Mar 2023), BrainsWay's revenue was $6.62M, beating the average analysts' forecast of $6.4M by 3.52%. The company's EBITDA was $-3.341M, beating the average prediction of $-1.458M by 129.21%. BrainsWay's net income was $-2.431M, beating the average estimation of $-1.616M by 50.40%. The company's SG&A was $6.72M, beating the average forecast of $4.89M by 37.39%. Lastly, the company's EPS was $-0.14, beating the average prediction of $-0.108 by 29.92%